Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S
View ORCID ProfileBernardo García-Carreras, Matt D. T. Hitchings, Michael A. Johansson, Matthew Biggerstaff, Rachel B. Slayton, Jessica M. Healy, Justin Lessler, Talia Quandelacy, View ORCID ProfileHenrik Salje, Angkana T. Huang, Derek A. T. Cummings
doi: https://doi.org/10.1101/2022.09.13.22279702
Bernardo García-Carreras
1Department of Biology, University of Florida, Gainesville, FL, USA
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
Matt D. T. Hitchings
3Department of Biostatistics, University of Florida, Gainesville, FL, USA
Michael A. Johansson
4COVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, GA, USA
Matthew Biggerstaff
4COVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, GA, USA
Rachel B. Slayton
4COVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, GA, USA
Jessica M. Healy
4COVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, GA, USA
Justin Lessler
5Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
6UNC Carolina Population Center, Chapel Hill, NC, USA
Talia Quandelacy
7University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Henrik Salje
8Department of Genetics, University of Cambridge, Cambridge, UK
Angkana T. Huang
8Department of Genetics, University of Cambridge, Cambridge, UK
Derek A. T. Cummings
1Department of Biology, University of Florida, Gainesville, FL, USA
2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted September 18, 2022.
Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S
Bernardo García-Carreras, Matt D. T. Hitchings, Michael A. Johansson, Matthew Biggerstaff, Rachel B. Slayton, Jessica M. Healy, Justin Lessler, Talia Quandelacy, Henrik Salje, Angkana T. Huang, Derek A. T. Cummings
medRxiv 2022.09.13.22279702; doi: https://doi.org/10.1101/2022.09.13.22279702
Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S
Bernardo García-Carreras, Matt D. T. Hitchings, Michael A. Johansson, Matthew Biggerstaff, Rachel B. Slayton, Jessica M. Healy, Justin Lessler, Talia Quandelacy, Henrik Salje, Angkana T. Huang, Derek A. T. Cummings
medRxiv 2022.09.13.22279702; doi: https://doi.org/10.1101/2022.09.13.22279702
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12176)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3834)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)